Inovio Pharmaceuticals
(NASDAQ) INO
Inovio Pharmaceuticals Financials at a Glance
Market Cap
$91.32M
Revenue (TTM)
$0.00
Net Income (TTM)
-$84.93M
EPS (TTM)
-$1.71
P/E Ratio
-0.65
Dividend
$0.00
Beta (Volatility)
1.59 (High)
Dividend
$0.00
Beta (Volatility)
1.59 (High)
Price
$1.12
Volume
2,742,638.504
Open
$1.11
Price
$1.12
Volume
2,742,638.504
Open
$1.11
Previous Close
$1.12
Daily Range
$1.07 - $1.16
52-Week Range
$1.03 - $2.98
Estimated Earnings Date
Aug 12, 2026
Dividend
$0.00
Beta (Volatility)
1.59 (High)
Price
$1.12
Volume
2,742,638.504
Open
$1.11
Previous Close
$1.12
Daily Range
$1.07 - $1.16
52-Week Range
$1.03 - $2.98
Estimated Earnings Date
Aug 12, 2026
INO News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Inovio Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
112
CEO
Jacqueline E. Shea, PhD
Website
www.inovio.comHeadquarters
Plymouth Meeting, PA 19462, US
INO Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-296%
Return on Capital
-7%
Return on Assets
-2%
Earnings Yield
-1.54%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$91.32M
Shares Outstanding
82.27M
Volume
2.74M
Avg. Volume
2.70M
Financials (TTM)
Gross Profit
$65.34K
Operating Income
-$86.82M
EBITDA
-$81.96M
Operating Cash Flow
-$88.63M
Capital Expenditure
-$285.70K
Free Cash Flow
-$88.92M
Cash & ST Invst.
$58.51M
Total Debt
$9.37M
Inovio Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
-100.0%
Gross Profit
-$745.46K
-1240.8%
Gross Margin
0.00%
N/A
Market Cap
$91.32M
N/A
Market Cap/Employee
$681.52K
N/A
Employees
134
N/A
Net Income
-$19.68M
+0.1%
EBITDA
-$18.94M
+0.1%
Quarterly Fundamentals
Total Cash
$37.68M
-44.9%
Total Debt
$8.70M
-22.9%
Accounts Receivable
$0.00
-100.0%
Inventory
$0.00
N/A
Long Term Debt
$5.79M
-33.5%
Short Term Debt
$2.91M
+12.9%
Return on Assets
-1.71%
N/A
Return on Invested Capital
-7.06%
N/A
Free Cash Flow
-$21.59M
+19.8%
Operating Cash Flow
-$21.59M
+19.7%